NCT04354220

Brief Summary

End-tidal CO2 measurements in children will be assessed for their accuracy with arterial CO2 measurements.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
178

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2019

Completed
1 year until next milestone

First Posted

Study publicly available on registry

April 21, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

June 9, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 18, 2022

Status Verified

May 1, 2022

Enrollment Period

3.6 years

First QC Date

April 16, 2019

Last Update Submit

May 17, 2022

Conditions

Keywords

capnographyend-tidal CO2critically ill childrenventilatedaccuracy

Outcome Measures

Primary Outcomes (1)

  • Accuracy of end-tidal Carbon Dioxide (PetCO2) values in comparison to arterial Carbon Dioxide (PaCO2) values in invasively and non-invasively ventilated critically ill children without lung or heart disease

    Mean absolute measurement difference between simultaneously obtained PaCO2 and PetCO2 values (bias) and their 95% limits of agreement (precision) in children and newborns without cardiopulmonary dysfunction. Units of measure will be in kilopascal (kPa) for PetCO2 and PaCO2, respectively.

    On average every participant will be assessed for 5 days

Secondary Outcomes (1)

  • Accuracy of end-tidal Carbon Dioxide (PetCO2) values in comparison to arterial Carbon Dioxide (PaCO2) values in invasively and non-invasively ventilated critically ill children with lung and or heart disease

    On average every participant will be assessed for 5 days

Study Arms (4)

no shunt, no lung injury

ventilated newborns / infants / children with healthy lungs and without or corrected congenital heart disease and no intra-/extra-cardiac shunt

Diagnostic Test: capnography monitoringDiagnostic Test: arterial blood gas

mild lung injury

ventilated newborns / infants / children with mild lung injury (OI between 4 and 8)

Diagnostic Test: capnography monitoringDiagnostic Test: arterial blood gas

moderate-severe lung injury

ventilated newborns / infants / children with moderate or severe lung injury (OI above 8)

Diagnostic Test: capnography monitoringDiagnostic Test: arterial blood gas

shunt lesion

ventilated newborns / infants / children with cyanotic heart diseases and therefore existing intra-cardiac or extra- cardiac right-left shunt lesions

Diagnostic Test: capnography monitoringDiagnostic Test: arterial blood gas

Interventions

capnography monitoringDIAGNOSTIC_TEST

routinely used capnography monitoring

mild lung injurymoderate-severe lung injuryno shunt, no lung injuryshunt lesion
arterial blood gasDIAGNOSTIC_TEST

Routinely taken arterial blood gas values

mild lung injurymoderate-severe lung injuryno shunt, no lung injuryshunt lesion

Eligibility Criteria

Age1 Hour - 13 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Critically ill infants and children under invasive and non-invasive mechanical ventilation, regardless of their underlying acute or chronic diseases, as long as an arterial line for blood gas analyses is in situ.

You may qualify if:

  • Children on pressure controlled mechanical invasive or non-invasive ventilation on the Paediatric Intensive Care Unit of the University Children's Hospital Zurich
  • Newborns with a birthweight of at least 2.0 kg
  • Newborns with an age of at least 1 hour (age \> 60 minutes)
  • Children up to the last day of the 13th year of living
  • Ability of care taker or patient to understand verbal and written instructions and the general consent or informed consent in German or English
  • Obtained written general or informed consent as documented by signature
  • Available arterial line, i.e. a specific catheter inserted in an artery

You may not qualify if:

  • Care taker or participant unable for linguistic, mental or other reasons or unwilling to understand verbal or written information and to give written informed consent in German or English
  • Care taker not available
  • Newborns with a birthweight below 2.0 kg
  • Newborns younger than 1 hour (age \<60 minutes)
  • Children with an age of 14 years onwards
  • Missing arterial line
  • Patients dependent on any other kind of respiratory support that is not compatible with the PcCO2-sensor or where a high leakage in the respiratory circuit makes PcCO2 measurements impossible (nasal mask ventilation, low-flow-/high-flow-ventilation, rebreathing mask, high- frequency-oscillation)
  • Patients where the investigators act on the assumption that mechanical ventilation will be discontinued and/or the arterial line will be removed within 6 hours or where only one pair of values (arterial and endtidal CO2) can be compared
  • Patients with a cyanotic shunt lesion with a weight of 15 kg or above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Children's Hospital

Zurich, 8032, Switzerland

Location

MeSH Terms

Conditions

Infant, Newborn, DiseasesCritical IllnessRespiratory Distress SyndromeHeart Defects, CongenitalLung Diseases, ObstructiveLung Diseases, Interstitial

Interventions

Blood Gas Analysis

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsLung DiseasesRespiratory Tract DiseasesRespiration DisordersCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital Abnormalities

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Senior consultant and head of research

Study Record Dates

First Submitted

April 16, 2019

First Posted

April 21, 2020

Study Start

June 9, 2020

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

May 18, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations